ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

Marvin Schneiderman To Retire March 1

February 8, 1980

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

In Brief: New Clinical Education Program Guidelines Due; Maryland Has First Mammography Screening Law

May 30, 1986